Analysing quality of life (QOL) data may be complicated for several reasons, such as: repeated measures are obtained; data may be collected on ordered categorical responses; the instrument may have multidimensional scales, and complete data may not be available for all patients. In addition, it may
Missing forms and dropout in the TME quality of life substudy
β Scribed by H. Putter; C. A. M. Marijnen; E. Klein Kranenbarg; C. J. H. van de Velde; A. M. Stiggelbout
- Publisher
- Springer Netherlands
- Year
- 2005
- Tongue
- English
- Weight
- 234 KB
- Volume
- 14
- Category
- Article
- ISSN
- 0962-9343
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
Missing data has been a problem in many quality of life studies. This paper focuses upon the issues involved in handling forms which contain one or more missing items, and reviews the alternative procedures. One of the most widely practised approaches is imputation using the mean of all observed ite
Measurement of quality of life (QOL) in cancer clinical trials has increased in recent years as more groups realize the importance of such endpoints. A key problem has been missing data. Some QOL data may unavoidably be missing, as for example when patients are too ill to complete forms. Other impor
We summarize issues that arise when considering quality of life (QOL) data in cancer clinical trials, especially those related to missing data. We describe different types of missing data mechanisms, and discuss ways of assessing and testing missing data mechanisms. A section on presentation of stud
Assessment of health related quality of life has become an important endpoint in many cancer clinical trials. Because the participants of these trials often experience disease and treatment related morbidity and mortality, non-random missing assessments are inevitable. Examples are presented from se